Type(s) of Cancer
Esophageal
Esophageal
Study Phase
Phase 3
Study Completion Date
March 2012
March 2012
NCT00678535Uploaded 04-17-2015
Available for Download
PDS UID: Gastric_MerckKG_2008_130
Open-label, Randomized, Controlled, Multicenter Phase III Study Investigating Cetuximab in Combination With Capecitabine (Xeloda, X) and Cisplatin (P) Versus XP Alone as First-line Treatment for Subjects With Advanced Gastric Adenocarcinoma Including Adenocarcinoma of the Gastroesophageal Junction
PDS UID: Gastric_Multipl_2008_415Go to Study
Enhancing the Analytic Capacity of Gastric_MerckKG_2008_130 using a Statistical Linkage Method to Append Socioeconomic and Health Care Access Variables from the Medical Expenditure Panel Survey
Files:
PROTOCOLEMR 200048-052_EXPAND_Redacted Clinical Study Protocol.pdf
CRFEMR200048-052_Expand_SAS annotated eCRF_.pdf
DATA DICTIONARYData Dictionary.pdf
DATA (COMPARATOR ARM)EMR200048-052_Expand_Raw Data control arm.zip